• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞来源的外泌体通过抑制NEDD4L稳定c-Myc增强肺癌的有氧糖酵解和化疗耐药性。

Exosomes Derived From Macrophages Enhance Aerobic Glycolysis and Chemoresistance in Lung Cancer by Stabilizing c-Myc via the Inhibition of NEDD4L.

作者信息

Wang Huan, Wang Lie, Pan Haiyan, Wang Yaona, Shi Miao, Yu Hang, Wang Chaoye, Pan Xinfu, Chen Zhijun

机构信息

Department of Cardiothoracic Surgery, Zhoushan Hospital, Zhejiang University, Zhoushan, China.

Department of Internal Medicine, Zhoushan Hospital, Zhejiang University, Zhoushan, China.

出版信息

Front Cell Dev Biol. 2021 Mar 4;8:620603. doi: 10.3389/fcell.2020.620603. eCollection 2020.

DOI:10.3389/fcell.2020.620603
PMID:33748098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7969980/
Abstract

As one of the most common and lethal cancer, lung cancer severely threatens the health of human. It has been reported that tumor-associated macrophages promote initiation, progression, as well as chemoresistance in human cancers. However, the underneath molecular mechanism that drives chemoresistance in lung cancer is yet not fully characterized. In this article, we demonstrated that M2 macrophage-derived exosomes (MDE) is the key factor to promote cisplatin-resistance in lung cancer. MDE exhibited high expression level of several miRNA including miR-3679-5p. Mechanistically, miR-3679-5p was delivered to lung cancer cells by MDE, downregulating the expression of a known E3 ligase, NEDD4L, which has been identified as a key regulator controlling the stability of c-Myc. Such decreased NEDD4L expression level resulted in the stabilization of c-Myc and elevated glycolysis. The enhanced glycolysis drives the chemoresistance in lung cancer. Taken together, our findings not only show that M2 macrophage induce chemoresistance in lung cancer through MDE mediated miR-3679-5R/NEDD4L/c-Myc signaling cascade, but also shed the light on the mechanism of the cross-talk between M2 macrophage and lung cancers. By pinpointing a potential novel survival signaling pathway, our data could provide a new potential therapeutic target for lung cancer treatment and management.

摘要

作为最常见且致命的癌症之一,肺癌严重威胁人类健康。据报道,肿瘤相关巨噬细胞在人类癌症中促进肿瘤起始、进展以及化疗耐药。然而,驱动肺癌化疗耐药的潜在分子机制尚未完全明确。在本文中,我们证明M2巨噬细胞衍生的外泌体(MDE)是促进肺癌顺铂耐药的关键因素。MDE表现出包括miR-3679-5p在内的几种miRNA的高表达水平。机制上,miR-3679-5p通过MDE传递至肺癌细胞,下调已知的E3连接酶NEDD4L的表达,NEDD4L已被确定为控制c-Myc稳定性的关键调节因子。NEDD4L表达水平的降低导致c-Myc的稳定和糖酵解增加。增强的糖酵解驱动肺癌的化疗耐药。综上所述,我们的研究结果不仅表明M2巨噬细胞通过MDE介导的miR-3679-5R/NEDD4L/c-Myc信号级联在肺癌中诱导化疗耐药,还揭示了M2巨噬细胞与肺癌之间的相互作用机制。通过确定一条潜在的新的生存信号通路,我们的数据可为肺癌治疗和管理提供一个新的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/64c2848d08c6/fcell-08-620603-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/1a3daf321280/fcell-08-620603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/f6032a353fda/fcell-08-620603-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/c4832b72fb2b/fcell-08-620603-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/fab90051ab18/fcell-08-620603-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/ce03fcbfd32d/fcell-08-620603-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/64c2848d08c6/fcell-08-620603-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/1a3daf321280/fcell-08-620603-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/f6032a353fda/fcell-08-620603-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/c4832b72fb2b/fcell-08-620603-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/fab90051ab18/fcell-08-620603-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/ce03fcbfd32d/fcell-08-620603-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf9/7969980/64c2848d08c6/fcell-08-620603-g0006.jpg

相似文献

1
Exosomes Derived From Macrophages Enhance Aerobic Glycolysis and Chemoresistance in Lung Cancer by Stabilizing c-Myc via the Inhibition of NEDD4L.巨噬细胞来源的外泌体通过抑制NEDD4L稳定c-Myc增强肺癌的有氧糖酵解和化疗耐药性。
Front Cell Dev Biol. 2021 Mar 4;8:620603. doi: 10.3389/fcell.2020.620603. eCollection 2020.
2
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer.M2 巨噬细胞衍生的外泌体促进结肠癌中的细胞迁移和侵袭。
Cancer Res. 2019 Jan 1;79(1):146-158. doi: 10.1158/0008-5472.CAN-18-0014. Epub 2018 Nov 6.
3
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.肿瘤相关巨噬细胞衍生的miR-21通过外泌体转移赋予胃癌细胞顺铂耐药性。
J Exp Clin Cancer Res. 2017 Apr 13;36(1):53. doi: 10.1186/s13046-017-0528-y.
4
Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.外泌体递送的 circRNA 通过 miR-122-PKM2 轴促进糖酵解诱导结直肠癌细胞的化疗耐药性。
Mol Oncol. 2020 Mar;14(3):539-555. doi: 10.1002/1878-0261.12629. Epub 2020 Jan 24.
5
MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway.骨髓间充质干细胞来源的 miR-1180 通过上调 Wnt 信号通路诱导卵巢癌细胞的糖酵解和化疗耐药性。
J Zhejiang Univ Sci B. 2019;20(3):219-237. doi: 10.1631/jzus.B1800190.
6
The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6.免疫微环境通过巨噬细胞衍生的 IL6 赋予结直肠癌的化疗耐药性。
Clin Cancer Res. 2017 Dec 1;23(23):7375-7387. doi: 10.1158/1078-0432.CCR-17-1283. Epub 2017 Sep 19.
7
SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC.SALL4介导的外泌体miR-146a-5p上调通过肝癌中的M2肿瘤相关巨噬细胞驱动T细胞耗竭。
Oncoimmunology. 2019 Apr 17;8(7):1601479. doi: 10.1080/2162402X.2019.1601479. eCollection 2019.
8
M2 Macrophage-Derived Exosomal lncRNA AFAP1-AS1 and MicroRNA-26a Affect Cell Migration and Metastasis in Esophageal Cancer.M2巨噬细胞衍生的外泌体长链非编码RNA AFAP1-AS1和微小RNA-26a影响食管癌细胞的迁移和转移
Mol Ther Nucleic Acids. 2020 Oct 4;22:779-790. doi: 10.1016/j.omtn.2020.09.035. eCollection 2020 Dec 4.
9
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B.M2巨噬细胞衍生的外泌体微小RNA-155-5p通过下调ZC3H12B促进结肠癌的免疫逃逸。
Mol Ther Oncolytics. 2021 Feb 6;20:484-498. doi: 10.1016/j.omto.2021.02.005. eCollection 2021 Mar 26.
10
Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.缺氧预处理间充质干细胞分泌的细胞外囊泡通过 miR-21-5p 递送来促进非小细胞肺癌细胞的生长和迁移以及巨噬细胞 M2 极化。
J Exp Clin Cancer Res. 2019 Feb 8;38(1):62. doi: 10.1186/s13046-019-1027-0.

引用本文的文献

1
Sirtuin family in lung adenocarcinoma.肺癌中的沉默调节蛋白家族。
Discov Oncol. 2025 Jul 23;16(1):1398. doi: 10.1007/s12672-025-03217-4.
2
Harnessing EVs-ncRNA for Lung Cancer: From Oncogenic Pathways to Novel Diagnostic and Therapeutic Strategies.利用细胞外囊泡非编码RNA用于肺癌研究:从致癌途径到新型诊断和治疗策略
Int J Nanomedicine. 2025 Jul 14;20:9031-9054. doi: 10.2147/IJN.S528115. eCollection 2025.
3
CXCL12-targeting siRNA nanoparticles alleviate immunosuppression and inhibit tumor progression in esophageal squamous cell carcinoma.

本文引用的文献

1
Exosomal MicroRNAs as Mediators of Cellular Interactions Between Cancer Cells and Macrophages.外泌体 microRNAs 作为癌细胞与巨噬细胞间细胞相互作用的介质。
Front Immunol. 2020 Jun 11;11:1167. doi: 10.3389/fimmu.2020.01167. eCollection 2020.
2
RNF8 induces β-catenin-mediated c-Myc expression and promotes colon cancer proliferation.RNF8 诱导 β-连环蛋白介导的 c-Myc 表达并促进结肠癌增殖。
Int J Biol Sci. 2020 May 1;16(12):2051-2062. doi: 10.7150/ijbs.44119. eCollection 2020.
3
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.
靶向CXCL12的小干扰RNA纳米颗粒可减轻食管鳞状细胞癌的免疫抑制并抑制肿瘤进展。
J Nanobiotechnology. 2025 Jul 16;23(1):519. doi: 10.1186/s12951-025-03476-x.
4
Developing a machine-learning model to enable treatment selection for neoadjuvant chemotherapy for esophageal cancer.开发一种机器学习模型,以实现食管癌新辅助化疗的治疗选择。
Sci Rep. 2025 Jul 15;15(1):25669. doi: 10.1038/s41598-025-11252-y.
5
Decoding the Tumor Microenvironment: Exosome-Mediated Macrophage Polarization and Therapeutic Frontiers.解码肿瘤微环境:外泌体介导的巨噬细胞极化与治疗前沿
Int J Biol Sci. 2025 Jun 20;21(9):4187-4214. doi: 10.7150/ijbs.114222. eCollection 2025.
6
Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions.外泌体介导的癌症化疗耐药性:机制、治疗意义及未来方向
Biomolecules. 2025 May 8;15(5):685. doi: 10.3390/biom15050685.
7
The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer.肿瘤相关巨噬细胞在非小细胞肺癌中的临床意义及潜在治疗靶点
Front Med (Lausanne). 2025 Apr 30;12:1541104. doi: 10.3389/fmed.2025.1541104. eCollection 2025.
8
Macrophage-derived exosomes in cancer: a double-edged sword with therapeutic potential.癌症中巨噬细胞衍生的外泌体:一把具有治疗潜力的双刃剑。
J Nanobiotechnology. 2025 Apr 26;23(1):319. doi: 10.1186/s12951-025-03321-1.
9
Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review).靶向非编码RNA以克服癌症中代谢重编程介导的耐药性(综述)
Int J Oncol. 2025 May;66(5). doi: 10.3892/ijo.2025.5741. Epub 2025 Mar 21.
10
Tumor-Associated Macrophages: Key Players in the Non-Small Cell Lung Cancer Tumor Microenvironment.肿瘤相关巨噬细胞:非小细胞肺癌肿瘤微环境中的关键角色
Cancer Med. 2025 Feb;14(3):e70670. doi: 10.1002/cam4.70670.
非小细胞肺癌靶向治疗的新兴治疗领域。
Signal Transduct Target Ther. 2019 Dec 17;4:61. doi: 10.1038/s41392-019-0099-9. eCollection 2019.
4
Blockade of lncRNA-ASLNCS5088-enriched exosome generation in M2 macrophages by GW4869 dampens the effect of M2 macrophages on orchestrating fibroblast activation.GW4869 阻断 M2 巨噬细胞中富含 lncRNA-ASLNCS5088 的外泌体生成,从而抑制 M2 巨噬细胞对成纤维细胞激活的调控作用。
FASEB J. 2019 Nov;33(11):12200-12212. doi: 10.1096/fj.201901610. Epub 2019 Aug 20.
5
Exosomes from Macrophages Exposed to Apoptotic Breast Cancer Cells Promote Breast Cancer Proliferation and Metastasis.暴露于凋亡乳腺癌细胞的巨噬细胞分泌的外泌体促进乳腺癌的增殖和转移。
J Cancer. 2019 Jun 2;10(13):2892-2906. doi: 10.7150/jca.31241. eCollection 2019.
6
The roles of glucose metabolic reprogramming in chemo- and radio-resistance.葡萄糖代谢重编程在化疗和放疗抵抗中的作用。
J Exp Clin Cancer Res. 2019 May 23;38(1):218. doi: 10.1186/s13046-019-1214-z.
7
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.巨噬细胞衍生的外泌体将 miR-223 递送至上皮性卵巢癌细胞以引发耐药表型。
J Exp Clin Cancer Res. 2019 Feb 15;38(1):81. doi: 10.1186/s13046-019-1095-1.
8
The dynamic nature of senescence in cancer.衰老在癌症中的动态特性。
Nat Cell Biol. 2019 Jan;21(1):94-101. doi: 10.1038/s41556-018-0249-2. Epub 2019 Jan 2.
9
Suppressing the secretion of exosomal miR-19b by gw4869 could regulate oxaliplatin sensitivity in colorectal cancer.通过 gw4869 抑制外泌体 miR-19b 的分泌可以调节结直肠癌细胞对奥沙利铂的敏感性。
Neoplasma. 2019 Jan 15;66(1):39-45. doi: 10.4149/neo_2018_180306N155. Epub 2018 Aug 9.
10
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer.M2 巨噬细胞衍生的外泌体促进结肠癌中的细胞迁移和侵袭。
Cancer Res. 2019 Jan 1;79(1):146-158. doi: 10.1158/0008-5472.CAN-18-0014. Epub 2018 Nov 6.